Skip to content
Bioregulators

Crystagen

Crystagen is the tripeptide Glu-Asp-Pro from the Khavinson bioregulator series, examined in a spleen ageing study. Approved buyers can apply for wholesale access.

US Peptide Distributors supplies Crystagen at wholesale to approved business buyers. Every lot is tested by an independent third-party laboratory (we use Freedom Diagnostics and ILS Labs): HPLC for purity and mass spectrometry for identity. Pricing is quoted by supply option: USA stock, USA-synthesized or overseas-sourced, and USA stock offers same-day shipping with no minimum order.

Updated

Synonyms
EDP, Glu-Asp-Pro
Formula
C14H21N3O8
Molecular weight
359.33 g/mol
Sequence
Glu-Asp-Pro

Approved buyers see pricing

Wholesale pricing is available to approved business buyers after they log in.

Supply and testing

  • Every lot third-party testedHPLC for purity, mass spectrometry for identity. Labs: Freedom Diagnostics and ILS Labs.
  • Three supply optionsSupply options for wholesale ordersUSA stock (ships from US inventory), USA-synthesized, overseas-sourced.Ask which options apply to this compound.
  • Same-day shipping on USA stockExpedited options available. Overseas-sourced orders typically take 7-10 days.
  • No minimum on USA stockOne box to thousands of kits, plus gram and kilogram powder.
  • COA in your company nameCan be added to an order and is provided with it.

Distributor programShipping times

Request a quote for Crystagen

A tripeptide with a proline end

Crystagen is glutamic acid-aspartic acid-proline (EDP), a three-residue peptide of roughly 359 g/mol. The only source I found that connects the trade name to the sequence is a 2022 modelling paper from Khavinson's group, which lists "Crystagen (EDP)" in a table of ultrashort peptides docked to membrane transporters, with an immunoprotector label. Its sequence also turns up in a docking study of short peptides binding DNA, where EDP is reported to bind the AGAT sequence, although that paper uses the three-letter code and not the name.

Proline is unusual in a peptide this short because it has no amide hydrogen and imposes a kink, so EDP is conformationally more restricted than its glycine- or alanine-ended relatives.

The one paper that names it

A 2014 report in Advances in Gerontology compared four short peptides, Vilon, Timogen, Crystagen and R-1, for effects on immune cells in the spleen during ageing. For Crystagen the abstract says only that it activates B-cells and that, unlike some of the others, it does not drive cell renewal in the ageing spleen. The authors present the four as having different immune-cell profiles; Vilon and R-1 act on T-helpers, and Timogen on B-cells through reduced apoptosis and increased proliferation. No dose, model details or effect sizes appear in the abstract, so I have not restated any.

Evidence summary

  • Identity rests on one research group's own tables.
  • One experimental paper names the compound, and it is a study of spleen ageing in a specialist journal.
  • No independent replication, and no human data, were located.

That makes Crystagen one of the least documented items in this series. Buyers who need a strong literature base should weigh that before ordering.

Specification notes

A short peptide ending in proline will usually appear as a single clean mass peak. Ask what the content figure includes and how any counterion was determined; our reference on labeling explains why research-use language appears on every lot. Supply is for approved business buyers, for laboratory research use only.

References

  1. Chervyakova NA, et al. [Molecular aspects of immunoprotective activity of peptides in spleen during the ageing process]. Adv Gerontol. 2014.
  2. Khavinson V, et al. Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers. Int J Mol Sci. 2022.

Questions

Where can I buy Crystagen in bulk?

US Peptide Distributors supplies Crystagen to approved business buyers. Apply for a buyer account to see wholesale pricing by supply option (USA stock, USA-synthesized or overseas-sourced). There is no minimum order on USA stock, and larger volumes are quoted on request.

Is Crystagen sold for use in humans?

No. US Peptide Distributors sells Crystagen to approved business buyers for laboratory research use only, not for use in humans.

Is each lot of Crystagen third-party tested?

Yes. Every lot US Peptide Distributors supplies is tested by an independent third-party laboratory (we use Freedom Diagnostics and ILS Labs): HPLC for purity and mass spectrometry for identity. Lot COAs appear on this page as they are uploaded.